Featured Articles
-
TrialScope EXTRA Keynotes Address Data Ownership, Health Communication
6/11/2026
Can your regulatory and protocol strategies keep pace with evolving data ownership, disclosure, and AI requirements? Explore key compliance risks, protections, and practical solutions.
-
A Mission To Expand Recruitment Territory
6/11/2026
Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.
-
2026 Annual Completed Clinical Trials Report: Strong Headwinds And Winds Of Change
6/11/2026
Are your Phase I–III/IV clinical studies prepared for today's regulatory landscape? Learn how leading organizations are addressing compliance, transparency, and data ownership risks.
-
FDA Nudges Sponsors To Disclose Clinical Trial Results
5/12/2026
In March, the US FDA sent thousands of reminders to submit clinical trial results to ClinicalTrials.gov or complete the federal-mandated National Library of Medicine quality control review process.
-
Ways To Avoid Rescue Trials From The Start
5/12/2026
What pushes a study into rescue mode? Explore the common causes of trial delays and how to address them before they impact timelines and outcomes.
-
A Guide To Patient Engagement And Recruitment Solutions
4/16/2026
In this text we explore strategic solutions to patient recruitment and engagement challenges, emphasizing the importance of comprehensive patient engagement and recruitment strategies.
-
Improving Rare Disease Recruitment With Data And AI
4/15/2026
Finding patients for rare disease clinical trials can be an uphill battle; fortunately, there are ways sponsors can address the most common stumbling blocks in the recruitment process.
-
Pharma R&D Annual Review Supplement: New Active Substances
4/15/2026
Last year was by some distance the best year ever in terms of new active substances. Explore the 105 new debuts that easily outstrips that of the previous record holder, 2021’s, 97.
-
Sol-Gel Builds Awareness Of Rare Skin Condition, Generates Leads
4/1/2026
Explore a 60-day HCP Awareness email campaign that surpassed industry benchmarks and generated a substantial number of leads.
-
Sneak Peek Of Pharma R&D Annual Review
3/23/2026
Drug development experts remain intent on pharma’s prospects, especially in China, which have overtaken the US in first-time new drugs and continues to nurture a robust pipeline.